Detalhe da pesquisa
1.
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
Lancet Oncol
; 24(7): 772-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276871
2.
The multidisciplinary management of cholangiocarcinoma.
Cancer
; 129(2): 184-214, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382577
3.
Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer.
Oncologist
; 28(1): 40-47, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130326
4.
Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases.
J Surg Oncol
; 125(8): 1260-1268, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212404
5.
Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study.
Ann Surg Oncol
; 28(13): 8152-8159, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448960
6.
Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers.
Ann Surg Oncol
; 28(13): 8567-8578, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34365557
7.
The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009-2018.
BMC Cancer
; 21(1): 889, 2021 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344325
8.
Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials.
J Natl Compr Canc Netw
; 18(4): 428-433, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259790
9.
Expert Commentary on Microsatellite Instability in Colorectal Cancer: The Evolving Role of Immunotherapy.
Dis Colon Rectum
; 66(10): 1307-1308, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493213
10.
Small Bowel Adenocarcinoma.
Clin Colon Rectal Surg
; 31(5): 267-277, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30186048
11.
A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir.
Clin Gastroenterol Hepatol
; 11(8): 1014-20.e1-2, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23602817
12.
Hepatitis E masquerading as drug-induced liver injury.
Hepatology
; 56(6): 2420-3, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23175167
13.
Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma.
J Natl Compr Canc Netw
; 11(9): 1101-8, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24029125
14.
A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.
J Clin Gastroenterol
; 47(9): 800-6, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23470640
15.
Estimating the Time Toxicity of Contemporary Systemic Treatment Regimens for Advanced Esophageal and Gastric Cancers.
Cancers (Basel)
; 15(23)2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067380
16.
Development and validation of a nomogram to predict pathological complete response in patients with locally advanced gastric adenocarcinoma treated with neoadjuvant chemotherapy in combination with PD-1 antibodies.
J Gastrointest Oncol
; 14(6): 2373-2383, 2023 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196541
17.
Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta-analysis.
Cancer Med
; 12(24): 21579-21591, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38069531
18.
Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis.
Surgery
; 173(6): 1314-1321, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36435651
19.
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
Cancer Med
; 12(12): 12986-12995, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37132281
20.
Estimation of time cost of anti-cancer drugs approved based on comparisons to best supportive care: A cross sectional analysis.
J Cancer Policy
; 34: 100363, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162749